Latest Trials Latest NewsFAQ

University of Alberta

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1908-01-01

Employees: 10K

Market Cap: -

Website: http://www.ualberta.ca

Clinical Trials

Ulcerative Colitis Relapse Prevention by Prebiotics

Not Applicable

Completed

Conditions: Ulcerative Colitis

Interventions: Dietary Supplement: Synergy-1
Dietary Supplement: Maltodextrin

First Posted Date: 2016-08-12

Last Posted Date: 2022-04-14

Lead Sponsor: University of Alberta

Target Recruit Count: 89

Registration Number: NCT02865707

Locations: 🇨🇦
University of Alberta, Edmonton, Alberta, Canada

SI + CC Versus 3:1 C:V Ratio During Neonatal CPR

Not Applicable

Completed

Conditions: Birth Asphyxia
Bradycardia
Heart Arrest

Interventions: Procedure: CC+SI

First Posted Date: 2016-08-08

Last Posted Date: 2024-08-29

Lead Sponsor: University of Alberta

Target Recruit Count: 27

Registration Number: NCT02858583

Locations: 🇨🇦
Royal Alexandra Hospital, Edmonton, Canada
🇨🇦
IWK Health Centre, Halifax, Canada
🇦🇹
Medical University Vienna, Vienna, Austria

and more 1 locations

IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study

Completed

Conditions: Crohn's Disease
Inflammatory Bowel Disease

First Posted Date: 2016-07-28

Last Posted Date: 2019-05-31

Lead Sponsor: University of Alberta

Target Recruit Count: 28

Registration Number: NCT02847884

Locations: 🇨🇦
Stollery Children's Hospital, Edmonton, Alberta, Canada
🇨🇦
SickKids, Toronto, Ontario, Canada

The Fontan Education Study: A Randomized Control Trial

Not Applicable

Completed

Conditions: Heart Defects, Congenital

Interventions: Other: Fontan Education Videos

First Posted Date: 2016-07-13

Last Posted Date: 2018-10-16

Lead Sponsor: University of Alberta

Target Recruit Count: 26

Registration Number: NCT02831790

Locations: 🇨🇦
Stollery Children's Hospital, Edmonton, Alberta, Canada

International Nutrition Audit in FORegut TuMors

Completed

Conditions: Esophageal Cancer
Head and Neck Cancer

First Posted Date: 2016-07-12

Last Posted Date: 2019-11-05

Lead Sponsor: University of Alberta

Target Recruit Count: 170

Registration Number: NCT02829489

Locations: 🇦🇺
Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
🇺🇸
University of California, Davis Medical Center, Sacramento, California, United States
🇳🇱
VU University Medical Center, Amsterdam, MB, Netherlands

and more 3 locations

Omental Islet Transplant

Phase 1

Completed

Conditions: Type 1 Diabetes

Interventions: Procedure: Omental Islet transplant
Drug: Anti-Thymocyte Globulin
Drug: Mycophenolate mofetil
Drug: Tacrolimus
Drug: Etanercept
Drug: Sirolimus

First Posted Date: 2016-07-01

Last Posted Date: 2022-05-09

Lead Sponsor: University of Alberta

Target Recruit Count: 4

Registration Number: NCT02821026

Locations: 🇨🇦
Clinical Islet Transplant Program, Edmonton, Alberta, Canada

Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation

Recruiting

Conditions: Lung Transplant Rejection

First Posted Date: 2016-06-24

Last Posted Date: 2024-08-05

Lead Sponsor: University of Alberta

Target Recruit Count: 700

Registration Number: NCT02812290

Locations: 🇦🇺
The Alfred Hospital, Monash University, Melbourne, Australia
🇨🇦
Alberta Transplant Applied Genomics Centre, University of Alberta, Edmonton, Alberta, Canada
🇺🇸
University of Texas at San Antonio, San Antonio, Texas, United States

and more 7 locations

The Impact of a High Protein Diet on Substrate Oxidation and Energy Metabolism

Not Applicable

Completed

Conditions: Dietary Modification

Interventions: Other: Diet

First Posted Date: 2016-06-23

Last Posted Date: 2019-08-28

Lead Sponsor: University of Alberta

Target Recruit Count: 20

Registration Number: NCT02811276

Locations: 🇨🇦
University of Alberta, Edmonton, Alberta, Canada

Protein Recommendation to Increase Muscle

Not Applicable

Completed

Conditions: Colorectal Cancer

Interventions: Behavioral: Dietary counselling
Other: Dietary Protein

First Posted Date: 2016-06-02

Last Posted Date: 2023-04-06

Lead Sponsor: University of Alberta

Target Recruit Count: 50

Registration Number: NCT02788955

Locations: 🇨🇦
University of Alberta, Edmonton, Alberta, Canada
🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada

A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG)

Phase 3

Completed

Conditions: Myasthenia Gravis

Interventions: Drug: Human normal immunoglobulin G (IgG)

First Posted Date: 2016-05-17

Last Posted Date: 2023-02-21

Lead Sponsor: University of Alberta

Target Recruit Count: 26

Registration Number: NCT02774239

Locations: 🇨🇦
University of Alberta, Edmonton, Alberta, Canada
🇨🇦
Vancouver General Hospital - Gordon & Leslie Diamond Health Care Centre, Vancouver, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy